Fig. 8From: N6-methyladenosine-related lncRNAs is a potential marker for predicting prognosis and immunotherapy in ovarian cancerTest set and overall set to verify the risk model. A The distribution map of the risk score of the test set. B Survival curve of the test set. C The ROC curve of the test set at one-, three-, and five-years. D Distribution map of the overall set of risk scores. E Overall set survival curve. F The ROC curve of the overall set of one-, three-, and five-yearsBack to article page